title: Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype.
abstract: Establishing peripheral CD8(+) T cell tolerance is vital to avoid immune mediated destruction of healthy self-tissues. However, it also poses a major impediment to tumor immunity since tumors are derived from self-tissue and often induce T cell tolerance and dysfunction. Thus, understanding the mechanisms that regulate T cell tolerance versus immunity has important implications for human health. Signals received from the tissue environment largely dictate whether responding T cells become activated or tolerant. For example, induced expression and subsequent ligation of negative regulatory receptors on the surface of self-reactive CD8(+) T cells are integral in the induction of tolerance. We utilized a murine model of T cell tolerance to more completely define the molecules involved in this process. We discovered that, in addition to other known regulatory receptors, tolerant self-reactive CD8(+) T cells distinctly expressed the surface receptor neuropilin-1 (Nrp1). Nrp1 was highly induced in response to self-antigen, but only modestly when the same antigen was encountered under immune conditions, suggesting a possible mechanistic link to T cell tolerance. We also observed a similar Nrp1 expression profile on human tumor infiltrating CD4(+) and CD8(+) T cells. Despite high expression on tolerant CD8(+) T cells, our studies revealed that Nrp1 had no detectable role in the tolerant phenotype. Specifically, Nrp1-deficient T cells displayed the same functional defects as wild-type self-reactive T cells, lacking in vivo cytolytic potential, IFNγ production, and antitumor responses. While reporting mostly negative data, our findings have therapeutic implications, as Nrp1 is now being targeted for human cancer therapy in clinical trials, but the precise molecular pathways and immune cells being engaged during treatment remain incompletely defined.
authors.affiliation: Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, Missouri, United States of America.
authors.forename: Stephanie R
authors.initials: SR
authors.lastname: Jackson
authors.affiliation: Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, Missouri, United States of America.
authors.forename: Melissa
authors.initials: M
authors.lastname: Berrien-Elliott
authors.affiliation: Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, Missouri, United States of America.
authors.forename: Jinyun
authors.initials: J
authors.lastname: Yuan
authors.affiliation: Saint Louis University School of Medicine, Department of Surgery, St. Louis, Missouri, United States of America; Saint Louis University Cancer Center, St. Louis, Missouri, United States of America.
authors.forename: Eddy C
authors.initials: EC
authors.lastname: Hsueh
authors.affiliation: Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, Missouri, United States of America; Saint Louis University Cancer Center, St. Louis, Missouri, United States of America.
authors.forename: Ryan M
authors.initials: RM
authors.lastname: Teague
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D001324:Autoantigens / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D045142:Cross-Priming / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D007167:Immunotherapy; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D008099:Liver / Q000378:metabolism; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008810:Mice, Inbred C57BL; D039942:Neuropilin-1 / Q000378:metabolism*; D010641:Phenotype
chemical_list: D001324:Autoantigens; D039942:Neuropilin-1